Possible Role of Coenzyme Q10 in Prevention of Contrast Induced Nephropathy in Patients With Acute Coronary Syndrome Undergoing Coronary Angiography With or Without Intervention.
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
In this study the investigators aim to study the effect of supplementation of CoQ10 in decreasing the incidence of contrast induced acute kidney injury in patients with acute coronary syndrome undergoing coronary angiography.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Patients who are 18 years or older.
• ST-elevation myocardial infarction (STEMI).
• Non ST-elevation myocardial infarction( NSTEMI).
• Unstable Angina (UA)
Locations
Other Locations
Egypt
Ain Shams university hospitals
RECRUITING
Cairo
Ramy Mohamed Mostafa
NOT_YET_RECRUITING
Cairo
Contact Information
Primary
Ramy Mohamed, Resident
96ramymohamed22@gmail.com
01002820102
Backup
Ramy Mohamed mostafa, Resident
96ramymohamed22@gmail.com
01002820102
Time Frame
Start Date: 2024-06-15
Estimated Completion Date: 2024-11-01
Participants
Target number of participants: 250
Treatments
Experimental: Coenzyme Q10 100 Milligrams Oral Capsule
Coenzyme Group received coenzyme Q10 in addition to the the standard preventive measures
Placebo_comparator: Placebo group
Placebo Group received only the standard preventive measures
Related Therapeutic Areas
Sponsors
Leads: Ain Shams University